ReShape Lifesciences
(NASDAQ) RSLS
This security has been delisted. This page is retained for historical reference.
RSLS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowRSLS Financials
Key Financial Metrics (TTM)
Gross Margin
54%
Operating Margin
-6%
Net Income Margin
-5%
Return on Equity
-4%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$218.77K
Operating Income
$10.35M
EBITDA
$10.34M
Operating Cash Flow
$0.00
Capital Expenditure
$0.00
Free Cash Flow
$0.00
Cash & ST Invst.
$4.98M
Total Debt
$31.26K
ReShape Lifesciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.07M
-214.7%
Gross Profit
$1.08M
-181.8%
Gross Margin
52.14%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
17
N/A
Net Income
$488.29K
+127.7%
EBITDA
$583.47K
+191.6%
Quarterly Fundamentals
Net Cash
$4.95M
+1907.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$31.26K
-96.6%
Return on Assets
-1.69%
N/A
Return on Invested Capital
-3.77%
N/A
Free Cash Flow
$5.76M
-738.0%
Operating Cash Flow
$5.76M
-738.0%